Stock Research for ELGX

ELGX
Current Price

$4.0500


Latest Update: 2018-02-23 16:00:00

High
$ 4.0600
Low
$ 4.0500
Close
$ 4.0550
Volume
31537
 
  

Featured Broker: TradeStation

Get the due diligence for another stock.

 

ELGX Stock Chart & Research Data

The ELGX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ELGX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


ELGX Due diligence Resources & Stock Charts

The ELGX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View ELGX Detailed Price Forecast - CNN Money CNN View ELGX Detailed Summary - Google Finance
Yahoo View ELGX Detailed Summary - Yahoo! Finance Zacks View ELGX Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View ELGX Trends & Analysis - Trade-Ideas Barrons View ELGX Major Holders - Barrons
NASDAQ View ELGX Call Transcripts - NASDAQ Seeking View ELGX Breaking News & Analysis - Seeking Alpha
Spotlight View ELGX Annual Report - CompanySpotlight.com OTC Report View ELGX OTC Short Report - OTCShortReport.com
TradeKing View ELGX Fundamentals - TradeKing Charts View ELGX SEC Filings - Bar Chart
WSJ View Historical Prices for ELGX - The WSJ Morningstar View Performance/Total Return for ELGX - Morningstar
MarketWatch View the Analyst Estimates for ELGX - MarketWatch CNBC View the Earnings History for ELGX - CNBC
StockMarketWatch View the ELGX Earnings - StockMarketWatch MacroAxis View ELGX Buy or Sell Recommendations - MacroAxis
Bullish View the ELGX Bullish Patterns - American Bulls Short Pains View ELGX Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View ELGX Stock Mentions - StockTwits PennyStocks View ELGX Stock Mentions - PennyStockTweets
Twitter View ELGX Stock Mentions - Twitter Invest Hub View ELGX Investment Forum News - Investor Hub
Yahoo View ELGX Stock Mentions - Yahoo! Message Board Seeking Alpha View ELGX Stock Mentions - Seeking Alpha




Financial & Transaction Holdings

SECform4 View Insider Transactions for ELGX - SECform4.com Insider Cow View Insider Transactions for ELGX - Insider Cow
CNBC View ELGX Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for ELGX - OTC Markets
Yahoo View Insider Transactions for ELGX - Yahoo! Finance NASDAQ View Institutional Holdings for ELGX - NASDAQ


Stock Charts

FinViz View ELGX Stock Insight & Charts - FinViz.com StockCharts View ELGX Investment Charts - StockCharts.com
BarChart View ELGX Stock Overview & Charts - BarChart Trading View View ELGX User Generated Charts - Trading View


Latest Financial News for ELGX

Endologix reports 4Q loss
Posted on Wednesday February 21, 2018

On a per-share basis, the Irvine, California-based company said it had a loss of 17 cents. Losses, adjusted for non-recurring costs and restructuring costs, came to 8 cents per share. The results exceeded ...


John McDermott Steps Down as Chief Executive Officer of Endologix, Inc.
Posted on Wednesday February 21, 2018

Endologix, Inc.  , a developer and marketer of innovative treatments for aortic disorders, announced today that John McDermott is stepping down as the Company’s Chief Executive Officer.


Endologix Reports Fourth Quarter and Fiscal Year 2017 Financial Results
Posted on Wednesday February 21, 2018

Endologix, Inc. , a developer and marketer of innovative treatments for aortic disorders, today announced financial results for the fourth quarter and fiscal year ended December 31, 2017.


Endologix, Inc. to Host Earnings Call
Posted on Wednesday February 21, 2018

NEW YORK, NY / ACCESSWIRE / February 21, 2018 / Endologix, Inc. (NASDAQ: ELGX ) will be discussing their earnings results in their Q4 Earnings Call to be held on February 21, 2018 at 4:30 PM Eastern Time. ...


John McDermott Steps Down as Chief Executive Officer of Endologix, Inc.
Business Wire (press release) - Feb 21, 2018
IRVINE, Calif.--(BUSINESS WIRE)--Endologix, Inc. (Nasdaq:ELGX), a developer and marketer of innovative treatments for aortic disorders, announced today that John McDermott is stepping down as the Company's Chief Executive Officer.
Endologix Inc. (ELGX) Plunges 7.65% on February 22 - Equities.com
John McDermott Steps Down as Endologix (ELGX) CEO - StreetInsider.com

Endologix Q4 Earnings Preview
Benzinga - Feb 21, 2018
Endologix (NASDAQ: ELGX) announces its next round of earnings Wednesday. Here is Benzinga's everything-that-matters guide for today's Q4 earnings announcement.

Endologix, Inc. to Present at the Leerink Partners 7
Business Wire (press release) - Jan 30, 2018
IRVINE, Calif.--(BUSINESS WIRE)--Endologix, Inc. (Nasdaq:ELGX), a developer and marketer of innovative treatments for aortic disorders, today announced that John McDermott, Chief Executive Officer, and Vaseem Mahboob, Chief Financial Officer, will ...

Is This A Catalyst To Buy Endologix Inc (NASDAQ:ELGX)?
Simply Wall St - Feb 16, 2018
Trailing twelve-month data shows us that Endologix Inc's (NASDAQ:ELGX) earnings loss has accumulated to -US$76.80M. Although some investors expected this, their belief in the path to profitability for Endologix may be wavering.
Endologix, Inc. (ELGX): What's the Story? - StockNewsJournal
Endologix Inc. (ELGX) Soars 11.08% on February 15 - Equities.com

Enter a stock symbol to view the stock details.